Silvercrest Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-180,502
| Closed | -$3.64M | – | 883 |
|
|
2021
Q3 | $3.64M | Buy |
180,502
+33,686
| +23% | +$679K | 0.02% | 420 |
|
|
2021
Q2 | $5.48M | Sell |
146,816
-292
| -0.2% | -$10.9K | 0.04% | 376 |
|
|
2021
Q1 | $3.76M | Sell |
147,108
-18,620
| -11% | -$476K | 0.03% | 419 |
|
|
2020
Q4 | $3.65M | Sell |
165,728
-26,477
| -14% | -$583K | 0.03% | 399 |
|
|
2020
Q3 | $3.46M | Buy |
192,205
+104,745
| +120% | +$1.88M | 0.03% | 392 |
|
|
2020
Q2 | $2.22M | Buy |
+87,460
| New | +$2.22M | 0.02% | 446 |
|